In their Sept. 20 letter, Reps. Greg Walden, R-Ore., and Tim Murphy, R-Pa., expressed concern about the recent Petya malware attacks, which affected operations and distribution at pharmaceutical giant Kenilworth, N.J.-based Merck.
Although there is no evidence the manufacturing disruption at Merck resulted in patient harm, the representatives still said it raised concerns about the drug supply chain. They requested HHS brief the committee on actions the department has taken to understand and respond to the Petya cyberattacks, as well as its “policies, plans and procedures for addressing potential drug shortages or other associated consequences caused by cyber infections.”
“Learning from this event will not only benefit the healthcare sector, but also the millions of patients who depend on the availability of its products and services,” they wrote.
More articles on supply chain:
AmerisourceBergen commits $100k+ to hurricane relief efforts
Tips for supply chain leaders: Be a problem-solver
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.